سعر بروستيترول 10مجم 30 اقراص 2024

Alfuzosin hydrochloride 10 mg modified-release tablets, pack of 30 (Eva Pharma, Egypt).

• Signs and symptoms of benign prostatic hyperplasia (not for hypertension; not for children).Population: Adult menDailyMed (U.S. National Library of Medicine)

• Dizziness, upper respiratory tract infection, headache and fatigue (>=2% and more than placebo).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Moderate or severe hepatic impairment (Child-Pugh B and C).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Co-administration with potent CYP3A4 inhibitors such as ketoconazole, itraconazole or ritonavir.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Known hypersensitivity to alfuzosin or any component.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Postural hypotension/syncope, especially with antihypertensives or nitrates.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Use with caution in severe renal impairment (CrCl <30 mL/min) and in mild hepatic impairment.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Do not combine with other alpha-adrenergic antagonists.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir)Contraindicated; alfuzosin levels increased.DailyMed (U.S. National Library of Medicine)
• PDE5 inhibitorsPossible symptomatic hypotension; use with caution.DailyMed (U.S. National Library of Medicine)

• Not indicated for use in women; no adequate human data; animal studies not teratogenic.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)